CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-07 | Burns James William Chief Legal Officer | Sale 10b5-1 | −13,411 | $52.00 | $697K | 24,041 |
| 2024-11-07 | Burns James William Chief Legal Officer | Sale 10b5-1 | −8,341 | $52.56 | $438K | 15,700 |
| 2024-09-26 | Jones Cecilia Chief Financial Officer | Option exercise 10b5-1 | +7,473 | 22,700 | ||
| 2024-09-26 | Jones Cecilia Chief Financial Officer | Sale 10b5-1 | −2,542 | $49.03 | $125K | 20,158 |
| 2024-09-26 | Jones Cecilia Chief Financial Officer | Option exercise · Restricted stock units 10b5-1 | −7,473 | 7,472 | ||
| 2024-08-11 | Ballal Rahul D. Director | Option exercise | +2,302 | 7,992 | ||
| 2024-08-11 | Ballal Rahul D. Director | Option exercise · Restricted stock units | −2,302 | 2,302 | ||
| 2024-08-11 | Smith Cynthia Director | Option exercise | +2,302 | 7,992 | ||
| 2024-08-11 | Smith Cynthia Director | Option exercise · Restricted stock units | −2,302 | 2,302 | ||
| 2024-08-08 | Goff Brian Chief Executive Officer | Option exercise 10b5-1 | +22,691 | 89,883 | ||
| 2024-08-08 | Goff Brian Chief Executive Officer | Sale 10b5-1 | −11,091 | $42.75 | $474K | 78,792 |
| 2024-08-08 | Goff Brian Chief Executive Officer | Option exercise · Restricted stock units 10b5-1 | −22,691 | 22,691 | ||
| 2024-07-01 | Gheuens Sarah Chief Medical Officer | Option exercise 10b5-1 | +8,375 | 47,441 | ||
| 2024-07-01 | Gheuens Sarah Chief Medical Officer | Sale 10b5-1 | −3,705 | $43.85 | $162K | 43,736 |
| 2024-07-01 | Gheuens Sarah Chief Medical Officer | Option exercise · Restricted stock units 10b5-1 | −8,375 | 16,749 | ||
| 2024-06-20 | FOUSE JACQUALYN A Director | Grant or award · Restricted stock units | +2,120 | 2,120 | ||
| 2024-06-20 | FOUSE JACQUALYN A Director | Grant or award · Stock options (right to buy) | +11,774 | 11,774 | ||
| 2024-06-20 | Smith Cynthia Director | Grant or award · Restricted stock units | +2,120 | 2,120 | ||
| 2024-06-20 | Smith Cynthia Director | Grant or award · Stock options (right to buy) | +11,774 | 11,774 | ||
| 2024-06-20 | CAPELLO JEFFREY D Director | Grant or award · Restricted stock units | +2,120 | 2,120 |
Page 19 of 48 · 941 trades